First Header Logo Second Header Logo

Connection

Agshin Taghiyev to Male

This is a "connection" page, showing publications Agshin Taghiyev has written about Male.
Connection Strength

0.144
  1. Taghiyev AF, Guseva NV, Glover RA, Rokhlin OW, Cohen MB. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. Cancer Biol Ther. 2006 Sep; 5(9):1199-205.
    View in: PubMed
    Score: 0.020
  2. Taghiyev AF, Guseva NV, Sturm MT, Rokhlin OW, Cohen MB. Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. Cancer Biol Ther. 2005 Apr; 4(4):382-90.
    View in: PubMed
    Score: 0.018
  3. Taghiyev AF, Guseva NV, Harada H, Knudson CM, Rokhlin OW, Cohen MB. Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaP. Mol Cancer Res. 2003 May; 1(7):500-7.
    View in: PubMed
    Score: 0.016
  4. Turkina AG, Logacheva NP, Stromskaya TP, Zabotina TN, Kuznetzov SV, Sachibzadaeva KK, Tagiev A, Juravlev VS, Khoroshko ND, Baryshnikov AY, Stavrovskaya AA. Studies of some mechanisms of drug resistance in chronic myeloid leukemia (CML). Adv Exp Med Biol. 1999; 457:477-88.
    View in: PubMed
    Score: 0.012
  5. Khoroshko ND, Mokeeva RA, Turkina AG, Arkhipova NV, Semenova EA, Zakharova AV, Kobzev IuN, Sakhibzadaeva KK, Tagiev AF. [The hypereosinophilic variant of Ph'-positive chronic myeloleukemia]. Ter Arkh. 1998; 70(7):29-37.
    View in: PubMed
    Score: 0.011
  6. Sieren JC, Meyerholz DK, Wang XJ, Davis BT, Newell JD, Hammond E, Rohret JA, Rohret FA, Struzynski JT, Goeken JA, Naumann PW, Leidinger MR, Taghiyev A, Van Rheeden R, Hagen J, Darbro BW, Quelle DE, Rogers CS. Development and translational imaging of a TP53 porcine tumorigenesis model. J Clin Invest. 2014 Sep; 124(9):4052-66.
    View in: PubMed
    Score: 0.009
  7. Rokhlin OW, Guseva NV, Taghiyev AF, Glover RA, Cohen MB. KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer. Cancer Biol Ther. 2010 Feb; 9(3):224-35.
    View in: PubMed
    Score: 0.006
  8. Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther. 2008 Aug; 7(8):1288-96.
    View in: PubMed
    Score: 0.006
  9. Rokhlin OW, Taghiyev AF, Bayer KU, Bumcrot D, Koteliansk VE, Glover RA, Cohen MB. Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biol Ther. 2007 May; 6(5):732-42.
    View in: PubMed
    Score: 0.005
  10. Rokhlin OW, Glover RB, Guseva NV, Taghiyev AF, Kohlgraf KG, Cohen MB. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. Mol Cancer Res. 2006 Feb; 4(2):113-23.
    View in: PubMed
    Score: 0.005
  11. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Chumakov PM, Kravchenko JE, Cohen MB. Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. Oncogene. 2005 Oct 13; 24(45):6773-84.
    View in: PubMed
    Score: 0.005
  12. Guseva NV, Taghiyev AF, Sturm MT, Rokhlin OW, Cohen MB. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines. Mol Cancer Res. 2004 Oct; 2(10):574-84.
    View in: PubMed
    Score: 0.004
  13. Rokhlin OW, Guseva NV, Taghiyev AF, Glover RA, Cohen MB. Multiple effects of N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) on apoptotic pathways in human prostatic carcinoma cell lines. Cancer Biol Ther. 2004 Aug; 3(8):761-8.
    View in: PubMed
    Score: 0.004
  14. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem. 2004 Jan 01; 91(1):70-99.
    View in: PubMed
    Score: 0.004
  15. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3. Prostate. 2002 Jun 01; 51(4):231-40.
    View in: PubMed
    Score: 0.004
  16. Rokhlin OW, Guseva NV, Tagiyev AF, Glover RA, Cohen MB. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Prostate. 2002 Jun 01; 52(1):1-11.
    View in: PubMed
    Score: 0.004
  17. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Syrbu SI, Cohen MB. TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP. Cancer Biol Ther. 2002; 1(6):631-7.
    View in: PubMed
    Score: 0.004
  18. Rokhlin OW, Guseva N, Tagiyev A, Knudson CM, Cohen MB. Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis. Oncogene. 2001 May 17; 20(22):2836-43.
    View in: PubMed
    Score: 0.003
  19. Surin VL, Luk'ianenko AV, Tagiev AF, Smirnova OV. [A new polymorphism in the human factor IX gene, useful for determining carriers of hemophilia B]. Genetika. 1994 Jun; 30(6):740-2.
    View in: PubMed
    Score: 0.002
  20. Surin VL, Tagiev AF, Solov'ev GIa, Luk'ianenko AV, Plutalov OV, Berlin IuA. [Use of the polymerase chain reaction to detect beta-thalassemia mutations in heterozygous carriers from Azerbaijan while performing prenatal DNA-diagnosis]. Genetika. 1993 May; 29(5):820-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.